Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cue Biopharma (CUE) Prepaid Assets (2017 - 2025)

Cue Biopharma's Prepaid Assets history spans 9 years, with the latest figure at $3.1 million for Q3 2025.

  • For Q3 2025, Prepaid Assets rose 84.92% year-over-year to $3.1 million; the TTM value through Sep 2025 reached $3.1 million, up 84.92%, while the annual FY2024 figure was $805000.0, 15.71% down from the prior year.
  • Prepaid Assets for Q3 2025 was $3.1 million at Cue Biopharma, up from $2.4 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $3.1 million in Q3 2025 and bottomed at $160000.0 in Q2 2021.
  • The 5-year median for Prepaid Assets is $1.9 million (2025), against an average of $1.7 million.
  • The largest annual shift saw Prepaid Assets skyrocketed 1238.75% in 2022 before it tumbled 32.31% in 2023.
  • A 5-year view of Prepaid Assets shows it stood at $954792.0 in 2021, then fell by 11.92% to $841000.0 in 2022, then grew by 13.56% to $955000.0 in 2023, then dropped by 15.71% to $805000.0 in 2024, then surged by 286.83% to $3.1 million in 2025.
  • Per Business Quant, the three most recent readings for CUE's Prepaid Assets are $3.1 million (Q3 2025), $2.4 million (Q2 2025), and $1.9 million (Q1 2025).